H2O AM’s United Therapeutics UTHR Stock Holding History

H2O AM’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,830	Closed	-$2.33M	–	95
2019 Q1	$2.33M	Sell	19,830 -11,370	-36%	-$1.32M	0.29%	51
2018 Q4	$3.28M	Buy	+31,200	New	+$3.62M	0.36%	46

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

H2O AM's UTHR Position: Q2 2019 in Review

H2O AM sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 19,830 shares — an estimated $2.33M sold.

H2O AM first reported a position in UTHR in Q4 2018 and held it in 2 quarters. The position peaked at $3.28M in Q4 2018. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

H2O AM reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
H2O AM sold 19,830 United Therapeutics shares in Q2 2019, an estimated $2.33M.
H2O AM first reported a position in United Therapeutics in Q4 2018 and held it in 2 quarters.
H2O AM's United Therapeutics position peaked at $3.28M in Q4 2018.
320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on H2O AM's 13F filing for Q2 2019, filed 13 Aug 2019.